Gaviola, June Mae P.

HRN: 22-21-65  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/26/2022
CEFUROXIME 1.5GM (VIAL)
11/26/2022
12/03/2022
IVTT
1.5g
Q8
S/p Ltcs
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Skin & Soft TissueReproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: